Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin
Crossref DOI link: https://doi.org/10.1208/s12248-016-9965-3
Published Online: 2016-09-08
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Olivares-Morales, Andrés http://orcid.org/0000-0001-9959-0810
Ghosh, Avijit
Aarons, Leon
Rostami-Hodjegan, Amin
Funding for this research was provided by:
University of Manchester
License valid from 2016-09-08